♟️ Monday 2 February 2026 Mon, 2 Feb 2026

Argenica Therapeutics has won a crucial regulatory waiver from the European Medicines Agency, removing the need for paediatric trials for its stroke drug ARG-007 and clearing the way for faster adult market approval in Europe.

Peak Processing Limited has completed a strategic rebrand and organisational restructure, securing new long-term manufacturing agreements and expanding product listings to strengthen its foothold in North America's regulated cannabis beverage markets.

BlueScope Steel welcomes Tania Archibald as its new MD&CEO, who unveils a focused agenda to accelerate value delivery amid a leadership transition and rejected acquisition bid.

Alicanto Minerals has won shareholder approval to acquire the Mt Henry Gold Project in Western Australia, unlocking a 915,000oz gold resource and appointing Jeff Sansom as CEO to spearhead growth.

Ora Banda Mining’s Phase 1 drilling at Round Dam reveals a significant gold mineralisation system with multiple high-grade shoots, indicating strong potential for large-scale surface mining near existing infrastructure.

ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.

Red Mountain Mining has launched an expanded soil sampling program at its Oaky Creek prospect in NSW, aiming to unlock multiple high-grade antimony-gold targets along a 3km strike. This move builds on impressive assay results and positions the company alongside Australia’s leading antimony projects.

PC Gold has unveiled a remarkable high-grade gold intercept at its Spring Hill project, hitting 25 metres at 36.83 grams per tonne gold in a newly identified Macau Link Zone that connects the Macau and Hong Kong lodes.